Vertex Pharmaceuticals, Inc. (VRTX) Posts Q1 Loss of 65c/Share; Reports Statistically Significant KALYDECO + VX-661 Ph. 2 Data
Go back to Vertex Pharmaceuticals, Inc. (VRTX) Posts Q1 Loss of 65c/Share; Reports Statistically Significant KALYDECO + VX-661 Ph. 2 Data| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 525.73 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $525.73 | 52 Week High | $134.71 | |||
| Open | $525.73 | 52 Week Low | $73.31 | |||
| Day High | $525.73 | P/E | N/A | |||
| Day Low | $525.73 | EPS | $-1.98 | |||
| Volume | 125 | |||||

